
Sign up to save your podcasts
Or


Many people are worried that their favorite deodorant is going to cause them an early death, but when it comes down to it, we’re more worried that we’re going to smell like death. This conundrum perfectly articulates the juggling act between the short term benefit and long term risk with skin care products. In an ideal world, regulators would keep us from harm’s way. In the real world, long-term cancer risk, hormone disruption, and even organ damage are difficult to track and quantify so this is an evolving discussion. On this week’s podcast, you’ll meet the CEO of a testing company focused on safety and efficacy for manufacturers.
Listen and learn:
Links
dermatest.com
ABOUT OUR GUEST
Marcel Voss is the CEO of Dermatest GmbH, a company that specializes in skin testing and analysis.
Like the Show?
By Lucas Rockwood4.8
928928 ratings
Many people are worried that their favorite deodorant is going to cause them an early death, but when it comes down to it, we’re more worried that we’re going to smell like death. This conundrum perfectly articulates the juggling act between the short term benefit and long term risk with skin care products. In an ideal world, regulators would keep us from harm’s way. In the real world, long-term cancer risk, hormone disruption, and even organ damage are difficult to track and quantify so this is an evolving discussion. On this week’s podcast, you’ll meet the CEO of a testing company focused on safety and efficacy for manufacturers.
Listen and learn:
Links
dermatest.com
ABOUT OUR GUEST
Marcel Voss is the CEO of Dermatest GmbH, a company that specializes in skin testing and analysis.
Like the Show?

568 Listeners

3,323 Listeners

1,101 Listeners

1,248 Listeners

12,766 Listeners

2,503 Listeners

2,045 Listeners

4,063 Listeners

3,543 Listeners

9,290 Listeners

8,187 Listeners

607 Listeners

1,360 Listeners

29,178 Listeners

1,194 Listeners